Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
235 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Show all (19)
  • (-) Currently Recruiting (3)
  • Closed (16)

Medical Condition

  • Show all (235)
  • Addiction (5)
  • Allergy, Asthma, & Immunology (1)
  • Autoimmune Disorders (3)
  • Bone & Muscle (2)
  • Cancer (11)
  • COVID-19 (Coronavirus) (8)
  • Diabetes (7)
  • Ear, Nose and Throat (7)
  • Endocrine & Metabolic Disease (2)
  • Gastrointestinal and Digestive Diseases (3)
  • Hair and Skin Disorders (2)
  • Healthy Volunteers (45)
  • Heart Disease (20)
  • Infectious Disease (11)
  • Liver Disease (13)
  • Lung Disease (2)
  • Neurological Disorders (31)
    • Alzheimer's Disease (6)
    • Cerebral Palsy (2)
    • Dementia (3)
    • Multiple Sclerosis (3)
    • Neuromuscular (4)
    • (-) Neuropathy (1)
    • Parkinson's Disease (2)
  • Nutrition (2)
  • Obesity (9)
  • Obstetrics & Gynecology (10)
  • Pediatrics (17)
  • Psychiatric Disorders (7)
    • Depression (3)
    • Eating Disorders (1)
    • (-) Schizophrenia (2)
  • Rehabilitation (2)
  • Stroke (2)
  • Transplant (12)
  • Vascular Conditions (1)
Displaying 1 - 3 of 3

Brain Imaging Study for Participants with Schizophrenia

Condition: Psychiatric Disorders / Schizophrenia
Investigator: Kiyohito Iigaya, PhD
Status: Currently Recruiting
Our lab is conducting brain imaging research studies investigating people's behavior. We are looking for people between the ages of 18 and 65 to be study participants. As a schizophrenia study participant, you will be asked to complete a set of self-report questionnaires probing personality traits. You will also complete a number of computer-based…
Read More

A Study to Test the Effects and Safety of Riliprubart in People with Chronic CIDP for Which the Usual Treatment Does Not Work

Condition: Neurological Disorders / Neuropathy
Investigator: Thomas Brannagan, MD
Status: Currently Recruiting
This is a global, multicenter, placebo-controlled, phase 3 study evaluating the efficacy and safety of riliprubart in adult participants with CIDP who are refractory or had an insufficient response to standard of care (SOC) therapies, defined as Ig administered IV (IVIg) or SC (SCIg), or corticosteroids. Treatment duration will be 48 weeks. Participant must…
Read More

Study to test how brain circuits may cause auditory hallucinations

Condition: Psychiatric Disorders / Schizophrenia
Investigator: Guillermo Horga, MD, PhD
Status: Currently Recruiting
In this study, we are trying to learn more about the symptoms of psychosis, specifically to learn how alterations in the brain may produce certain experiences (including voice hearing or auditory hallucinations) that are common in people with psychosis or schizophrenia. The study involves clinical interviews, computer tests, and magnetic resonance imaging (…
Read More
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Terms of Use Privacy Policy ©2026 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science